The Keloid Treatment Market is expected to exceed more than US$ 12 Billion by 2028 at a CAGR of 10% in the given forecast period.
Keloid is an overgrowth of the scar tissues that develop from a wound. keloid development typically happens once the wound has recovered. Keloids grow on the far side the border of a scar and transform a lump. The explanation for keloid development cannot be determined however it will develop once surgery, burn injury, piercing, trauma, acne, vaccination and different wounds or cuts. A growing concentrate on compensation of various advanced keloid therapies is additionally expected to drive revenue growth of the worldwide market. there’s a visible increase within the adoption of advanced treatment choices that may cut back the speed of repeat of cicatrix scars and take away such scars fully. Also, mixtures therapies also are accustomed improve the effectiveness of treatment and prohibit the repeat rate. However, complications bearing on keloid treatment and better repeat rate post treatment are a number of the factors expected to restrain revenue growth of the worldwide keloid treatment market.
Global Keloid Treatment Market is segmented based on the treatments type as, Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injection and Others. The report segments global Keloid Treatment Market based on end-use as Hospitals, Dermatology Clinics, Ambulatory Surgical Centres and Others.
Global Keloid Treatment Market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional Keloid Treatment Market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Global Keloid Treatment Market share consists of several players including Pacific World Corporation, Revitol Corporation Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Novartis AG, Renovo Group plc., Valeant Pharmaceuticals International Inc., Galena Biopharma, Inc., RXi Pharmaceuticals, Inc., and Avita Medical.
Keloid Treatment Market has been segmented as follows:
Keloid Treatment Market, By Treatment Type
Keloid Treatment Market, By End-Use
Keloid Treatment Market, By Region
The report covers:
Report scope:
The global Keloid Treatment Market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pacific World Corporation, Revitol Corporation Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Novartis AG, Renovo Group plc., Valeant Pharmaceuticals International Inc., Galena Biopharma, Inc., RXi Pharmaceuticals, Inc., and Avita Medical.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Digital pregnancy test kits market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Keloid Treatment Market, By Treatment Types
5.1. Key Points
5.2. Occlusive Dressing
5.3. Compression Therapy
5.4. Cryosurgery
5.5. Excision
5.6. Radiation Therapy
5.7. Laser Therapy
5.8. Interferon Therapy
5.9. Intralesional Corticosteroid Injection
5.10. Others
6. Keloid Treatment Market, By Application
6.1. Key Points
6.2. Hospitals
6.3. Dermatology Clinics
6.4. Ambulatory Surgical Centres
6.5. Others
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profile
8.1. Novartis AG
8.1.1. Company Overview
8.1.2. Product/Service Landscape
8.1.3. Financial Overview
8.1.4. Recent Developments
8.2. Sensus Healthcare
8.2.1. Company Overview
8.2.2. Product/Service Landscape
8.2.3. Financial Overview
8.2.4. Recent Developments
8.3. RXi Pharmaceuticals, Inc.
8.3.1. Company Overview
8.3.2. Product/Service Landscape
8.3.3. Financial Overview
8.3.4. Recent Developments
8.4. Sonoma Pharmaceuticals, Inc.
8.4.1. Company Overview
8.4.2. Product/Service Landscape
8.4.3. Financial Overview
8.4.4. Recent Developments
8.5. Perrigo Company plc.
8.5.1. Company Overview
8.5.2. Product/Service Landscape
8.5.3. Financial Overview
8.5.4. Recent Developments
8.6. Bristol-Myers Squibb Company
8.6.1. Company Overview
8.6.2. Product/Service Landscape
8.6.3. Financial Overview
8.6.4. Recent Developments
8.7. Pacific World Corporation
8.7.1. Company Overview
8.7.2. Product/Service Landscape
8.7.3. Financial Overview
8.7.4. Recent Developments
8.8. Valeant Pharmaceutical International, Inc.
8.8.1. Company Overview
8.8.2. Product/Service Landscape
8.8.3. Financial Overview
8.8.4. Recent Developments
8.9. Revitol Corporation
8.9.1. Company Overview
8.9.2. Product/Service Landscape
8.9.3. Financial Overview
8.9.4. Recent Developments
8.10. Avita Medical Limited
8.10.1. Company Overview
8.10.2. Product/Service Landscape
8.10.3. Financial Overview
8.10.4. Recent Developments
Keloid Treatment Market has been segmented as follows:
Keloid Treatment Market, By Treatment Type
Keloid Treatment Market, By End-User
Keloid Treatment Market, By Region
